Stefanie Geyh

1.0k total citations
18 papers, 623 citations indexed

About

Stefanie Geyh is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Stefanie Geyh has authored 18 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Stefanie Geyh's work include Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Mesenchymal stem cell research (6 papers). Stefanie Geyh is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Mesenchymal stem cell research (6 papers). Stefanie Geyh collaborates with scholars based in Germany, United States and Switzerland. Stefanie Geyh's co-authors include Thomas Schroeder, Rainer Haas, Guido Kobbe, Ulrich Germing, Christoph Zilkens, Frank Lyko, Derik Hermsen, Roland Fenk, Paul Jäger and Manuel Rodríguez‐Paredes and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Stefanie Geyh

16 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie Geyh Germany 10 443 254 197 123 70 18 623
Eugenia Flores‐Figueroa Mexico 15 537 1.2× 479 1.9× 200 1.0× 166 1.3× 126 1.8× 29 863
Gregory W. Roloff United States 13 229 0.5× 132 0.5× 168 0.9× 78 0.6× 81 1.2× 28 453
Cristina Robledo Spain 13 174 0.4× 163 0.6× 132 0.7× 42 0.3× 81 1.2× 27 399
Ikuta Tanaka Japan 5 370 0.8× 90 0.4× 205 1.0× 134 1.1× 158 2.3× 9 569
Patricia van den Hoogen Netherlands 8 329 0.7× 178 0.7× 477 2.4× 56 0.5× 26 0.4× 11 734
Mónica Ventura Ferreira Germany 6 191 0.4× 168 0.7× 199 1.0× 93 0.8× 50 0.7× 7 431
Safa Karandish United States 11 524 1.2× 395 1.6× 193 1.0× 125 1.0× 136 1.9× 13 733
Laura Forte Italy 5 197 0.4× 205 0.8× 95 0.5× 37 0.3× 40 0.6× 10 363
Borhane Guezguez Canada 13 149 0.3× 94 0.4× 259 1.3× 128 1.0× 118 1.7× 22 519
Paulina M. H. van Strien Netherlands 7 137 0.3× 135 0.5× 194 1.0× 94 0.8× 46 0.7× 11 400

Countries citing papers authored by Stefanie Geyh

Since Specialization
Citations

This map shows the geographic impact of Stefanie Geyh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Geyh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Geyh more than expected).

Fields of papers citing papers by Stefanie Geyh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Geyh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Geyh. The network helps show where Stefanie Geyh may publish in the future.

Co-authorship network of co-authors of Stefanie Geyh

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Geyh. A scholar is included among the top collaborators of Stefanie Geyh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Geyh. Stefanie Geyh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Koch, Annemarie, Roland Fenk, Uwe Maus, et al.. (2024). Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. Blood Advances. 8(10). 2575–2588. 4 indexed citations
2.
Koch, Annemarie, Ulrich Germing, Roland Fenk, et al.. (2024). Overlapping Stromal Alterations in Myeloid and Lymphoid Neoplasms. Cancers. 16(11). 2071–2071. 1 indexed citations
3.
Jäger, Paul, Christina Rautenberg, Jennifer Kaivers, et al.. (2023). Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience. Scientific Reports. 13(1). 10774–10774. 2 indexed citations
4.
Stuhldreier, Fabian, Thomas Lenz, Marcel Zimmermann, et al.. (2022). The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism. Cell Death and Disease. 13(11). 938–938. 7 indexed citations
5.
Böttcher, Martin, Konstantinos Panagiotidis, Heiko Bruns, et al.. (2022). Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subset. Blood Advances. 6(21). 5685–5697. 23 indexed citations
6.
Rautenberg, Christina, Ulrich Germing, Stefanie Stepanow, et al.. (2020). Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia. American Journal of Hematology. 96(1). E15–E17. 6 indexed citations
7.
Geyh, Stefanie, Daniel M. Waldera-Lupa, Anja Stefanski, et al.. (2019). Secretome analysis of human bone marrow derived mesenchymal stromal cells. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1867(4). 434–441. 39 indexed citations
8.
Rautenberg, Christina, Ulrich Germing, Sabrina Pechtel, et al.. (2019). Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS. Blood Cancer Journal. 9(11). 86–86. 23 indexed citations
9.
Rautenberg, Christina, Stefanie Stepanow, Michael Lauseker, et al.. (2019). Impact of Somatic Mutations and Pretransplant Strategies on the Outcome of Patients Allografted for MDS or Secondary AML. Blood. 134(Supplement_1). 4612–4612.
10.
Geyh, Stefanie, Manuel Rodríguez‐Paredes, Paul Jäger, et al.. (2018). Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia. Haematologica. 103(9). 1462–1471. 47 indexed citations
12.
Schroeder, Thomas, Christina Rautenberg, William Krüger, et al.. (2017). Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group. Annals of Hematology. 97(2). 335–342. 59 indexed citations
13.
Loges, Sonja, Isabel Ben‐Batalla, Michael Heuser, et al.. (2017). Axl blockade in vitro and in patients with high-risk MDS by the small molecule inhibitor BGB324.. Journal of Clinical Oncology. 35(15_suppl). 7059–7059. 2 indexed citations
14.
Schroeder, Thomas, Stefanie Geyh, Ulrich Germing, & Rainer Haas. (2016). Mesenchymal stromal cells in myeloid malignancies. Blood Research. 51(4). 225–225. 26 indexed citations
15.
Geyh, Stefanie, Manuel Rodríguez‐Paredes, Paul Jäger, et al.. (2015). Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia. Leukemia. 30(3). 683–691. 114 indexed citations
16.
Geyh, Stefanie, Simin Öz, Julia Fröbel, et al.. (2013). Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells. Leukemia. 27(9). 1841–1851. 177 indexed citations
17.
Geyh, Stefanie, Ron‐Patrick Cadeddu, Julia Fröbel, et al.. (2011). Analysis of Mesenchymal Stromal Cells (MSC) and Their Interactions with CD34 Stem and Progenitor Cells in Patients with Myelodysplastic Syndromes (MDS). Blood. 118(21). 2393–2393.
18.
Buchheiser, Anja, Stefanie Geyh, Teja Falk Radke, et al.. (2010). DLK-1 as a Marker to Distinguish Unrestricted Somatic Stem Cells and Mesenchymal Stromal Cells in Cord Blood. Stem Cells and Development. 19(10). 1471–1483. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026